Prodrugs of Phosphates and Phosphonates
- 1 February 2008
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (8), 2328-2345
- https://doi.org/10.1021/jm701260b
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Bis[(para-methoxy)benzyl] phosphonate prodrugs with improved stability and enhanced cell penetrationBioorganic & Medicinal Chemistry Letters, 2007
- Synthesis, Biochemical, and Cellular Evaluation of Farnesyl Monophosphate Prodrugs as Farnesyltransferase InhibitorsJournal of Medicinal Chemistry, 2007
- Phosphoramidate Pronucleotides: A Comparison of the Phosphoramidase Substrate Specificity of Human and Escherichia coli Histidine Triad Nucleotide Binding ProteinsMolecular Pharmaceutics, 2007
- 36 Pharmacokinetics and pharmacodynamics of pradefovir, a liver-targeting prodrug of PMEA in HBV patientsJournal of Hepatology, 2006
- An Improved Procedure for the Synthesis of Nucleoside PhosphoramidatesOrganic Process Research & Development, 2002
- Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin’s lymphoma – phase I/II studies and pharmacokineticsLeukemia, 1998
- The Role of 4-phosphonodifluoromethyl- and 4-phosphono-phenylalanine in the selectivity and cellular uptake of SH2 domain ligandsBioorganic & Medicinal Chemistry Letters, 1997
- Non-peptidic inhibitors of neutral endopeptidase 24.11 2. Design and pharmacology of orally active phosphonate prodrugsBioorganic & Medicinal Chemistry Letters, 1995
- Prodrugs of phosphonoformate: products, kinetics and mechanisms of hydrolysis of dibenzyl (methoxycarbonyl)phosphonateJournal of the Chemical Society, Perkin Transactions 2, 1991
- The synthesis, characterization, and preliminary biological evaluation of 1-β-D-arabinofuranosylcytosine-5′-diphosphate-L-1,2-dipalmitinBiochemical and Biophysical Research Communications, 1978